It only means the battery is rated to deliver more current
This brief examines the financialized business model of Novo Nordisk and Eli Lilly for the leading GLP-1 products Ozempic, Rybelsus, and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide)
doi: 10.1016/j.biomaterials.2017.02.016 232 SoltanianM.RajabalinejadA.RajabiR.MousaviM
The Legal Battle: Unpacking the Ozempic Lawsuits The heart of the legal battle against Ozempic revolves around allegations that the manufacturer, Novo Nordisk, failed to provide adequate warnings about the drugs potential to cause serious side effects
Early pricing indicated an entry cost of around 49 dollars for the first month, followed by a subscription model of roughly 99 dollars monthly
The plotter adds understanding to the process, even when the dosing decisions are predetermined by the pen's design